Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Electrospun nanofiber drug delivery systems and recent applications: An overview

Muratoglu S., Inal M., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ŞAHİN S.
Journal of Drug Delivery Science and Technology , cilt.92, 2024 (SCI-Expanded) identifier

Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation

Arslan A., YET B., NEMUTLU E., AKDAĞ ÇAYLI Y., EROĞLU H., ÖNER L.
Pharmaceutics , cilt.15, sa.2, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.

Akdag Y.
Pharmaceutical development and technology , cilt.28, sa.1, ss.124-137, 2023 (SCI-Expanded) identifier identifier identifier

Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation

POLAT H. K., Kurt N., AYTEKİN E., AKDAĞ ÇAYLI Y., Pehlivan S., ÇALIŞ S.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.38, sa.6, ss.412-423, 2022 (SCI-Expanded) identifier identifier identifier

The development and characterization of electrospun gelatin nanofibers containing indomethacin and curcumin for accelerated wound healing

Gulsun T., Inal M., Akdag Y., İZAT N., ÖNER L., ŞAHİN S.
Journal of Drug Delivery Science and Technology , cilt.67, 2022 (SCI-Expanded) identifier identifier

Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets

GÜLSÜN İNAL T., AKDAĞ ÇAYLI Y., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.25, sa.8, ss.999-1009, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Development of an Anti-Inflammatory Drug-Incorporated Biomimetic Scaffold for Corneal Tissue Engineering

Celebier S. K., Pehlivan S., DEMİRBİLEK M., Akinci M., VURAL İ., AKDAĞ ÇAYLI Y., et al.
Journal of Ocular Pharmacology and Therapeutics , cilt.36, sa.6, ss.433-446, 2020 (SCI-Expanded) identifier identifier identifier

Characterization and comparison of deferasirox fast disintegrating tablets prepared by direct compression and lyophilization methods

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.57, 2020 (SCI-Expanded) identifier identifier

Comparison of Dissolution Profiles and Apparent Permeabilities of Commercially Available Metformin Hydrochloride Tablets in Turkey

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.
DISSOLUTION TECHNOLOGIES , cilt.27, sa.1, 2020 (SCI-Expanded) Creative Commons License identifier identifier

Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0

Barenji R. V., Akdag Y., YET B., ÖNER L.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.567, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Effect of particle size and surfactant on the solubility, permeability and dissolution characteristics of deferasirox

Gulsun T., Akdag Y., İZAT N., ÖNER L., ŞAHİN S.
Journal of Research in Pharmacy , cilt.23, sa.5, ss.851-859, 2019 (SSCI) Creative Commons License identifier identifier

Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

Akdag Y., ŞAHİN S., NEMUTLU E., ÖNER L.
TURKISH JOURNAL OF CHEMISTRY , cilt.43, sa.3, ss.846-856, 2019 (SCI-Expanded) identifier identifier

Development and evaluation of terbutaline sulfate orally disintegrating tablets by direct compression and freeze drying methods

Gulsun T., Cayli Y., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
Journal of Drug Delivery Science and Technology , cilt.46, ss.251-258, 2018 (SCI-Expanded) identifier identifier

Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.

Akdag C., SAHIN S., BUTTINI F., BALDUCCI A., MONTANARI S., VURAL I., et al.
Drug development and industrial pharmacy , cilt.43, ss.1378-1389, 2017 (SCI-Expanded) identifier identifier identifier

Preparation and in vitro/in vivo evaluation of rofecoxib containing bovine serum albumin microspheres

Demirturk E., Gulsun T., Cayli Y., İZAT N., ŞAHİN S., ÖNER L.
Latin American Journal of Pharmacy , cilt.36, sa.6, ss.1096-1104, 2017 (SCI-Expanded) identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

FARMASÖTİK ENDÜSTRİDE FARMA 4.0 YAKLAŞIMI

Bebek G., AKDAG Y., ONER L.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.47, sa.3, ss.1058-1070, 2023 (Scopus) Creative Commons License identifier identifier

Effects of Surfactants on Albumin Nanoparticles

Akdag Y., Geyik Z. M.
Journal of Research in Pharmacy , cilt.26, sa.5, ss.1177-1189, 2022 (Scopus) identifier identifier identifier

Formulation and characterization of mometasone furoate and formoterol fumarate containing dry powder inhaler by spray drying and homogenization methods

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.
JOURNAL OF RESEARCH IN PHARMACY , cilt.26, sa.2, ss.383-396, 2022 (ESCI) Creative Commons License identifier identifier identifier

Evaluation of preparation methods for orally disintegrating tablets

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
Medicine Science , cilt.9, sa.1, ss.259-263, 2020 (Hakemli Dergi)

Development of dry powder inhaler formulations for drug delivery systems

Akdağ Çaylı Y.
Journal of Research in Pharmacy , cilt.23, sa.6, ss.1-15, 2019 (Hakemli Dergi)

Development of dry powder inhaler formulations for drug delivery systems

AKDAĞ ÇAYLI Y.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.6, ss.973-987, 2019 (ESCI) Creative Commons License identifier identifier

Dry Powder Inhalers: Formulations and Aerodynamic Behaviours

AKDAĞ ÇAYLI Y., ŞAHİN S., ÖNER L.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.38, sa.1, ss.39-52, 2018 (Scopus) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Dry Powder Inhaler Formulations Containing Gefitinib Nanoparticles

Geyik Z. M., Nacak B., Bilal M. N., Gülsün İnal T., Şahin S., Öner L., et al.
9th BBBB International Conference on Pharmaceutical Sciences 2022, Ljubljana, Slovenya, 15 - 17 Eylül 2022, ss.178-179

Development of besifloxacin loaded nanostructured lipid carrier and characterization studies

Kurt N., Polat H. K., Aytekin E., Akdağ Çaylı Y., Pehlivan S., Çalış S.
20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, ss.1-2

Effects of spray drying and lyophilization methods on aerodynamic parameters in dry powder inhalers

Akdağ Çaylı Y.
20th International Pharmaceutical Technology Symposium - IPTS 2022, Ankara, Türkiye, 21 - 23 Şubat 2022, ss.1-2

Gefitinib-human serum albumin nanoparticles production by nanoparticle-albumin bound (NAB™) technology

Geyik Z. M., Nacak B., Bilal M. N., Gülsün İnal T., Şahin S., Öner L., et al.
20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, ss.1-2

Effects of modifications in methyl cellulose nanoparticle production methods on particle size distribution

Taş B., Akdağ Çaylı Y., Pehlivan S., Aytekin E., Çopur T., Sağlam O., et al.
20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, ss.1-2

Validation of an HPLC method for the determination of talazoparib from nanoparticle formulations

Taş B., Akdağ Çaylı Y., Aytekin E., Pehlivan S., Öner L., Kaplan O.
3rd International Gazi Pharma Symposium Series (GPSS-2021), 8 - 10 Eylül 2021, ss.1-2

Effects of Production Method Variations on Particle Size Distribution of Ethyl Cellulose Nanoparticles

Taş B., Akdağ Çaylı Y., Aytekin E., Pehlivan S., Öner L.
13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 Haziran 2021, ss.1-2

HUMAN SERUM ALBUMIN NANOPARTICLES FOR TARGETED CANCER THERAPY

AKDAĞ ÇAYLI Y., GEYİK Z. M.
13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 Haziran 2021 Sürdürülebilir Kalkınma

Effects of Preparation Methods on Orally Disintegrating Tablets

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
International Multidisciplinary Symposium on Drug Research Development (DRD 2019), 1 - 03 Temmuz 2019

Ağız yolu ile uygulanan etkin maddelerin çözünürlük ve permeabilite özelliklerini arttırmak amacıyla formülasyon geliştirme sürecinde kullanılan yöntemler

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ŞAHİN S., ÖNER L.
2. Ulusal Marmara Eczacılık Kongresi (UMEK-2), Türkiye, 14 - 16 Kasım 2018

OPTIMIZATION OF NANOSYSTEMS CONTAINING ALBUMIN LINKED PACLITAXEL

AKDAĞ ÇAYLI Y., MURAT Z., EROĞLU H., ÖNER L.
19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018

Investigation of deferasirox permeability from lyophilized orally disintegrating tablet

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L., ŞAHİN S.
2017 AAPS Annual Meeting and Exposition, 12 - 15 Kasım 2017

Investigation of terbutaline sulfate permeability from orally disintegrating tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ÖNER L., ŞAHİN S.
2017 AAPS Annual Meeting and Exposition, 12 - 15 Kasım 2017

Development and Characterization of Indomethacin and Curcumin Containing Nanofibers

İNAL M., GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L., ŞAHİN S.
GPSS 2017, 11 - 13 Ekim 2017

Development and Evaluation of Lyophilized Orally Disintegrating Tablets Containing Metformin Hydrochloride and Glyburide

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÇETİN M., ÖNER L., ŞAHİN S.
77th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2017, 10 - 14 Eylül 2017

Antibiyotik İçeren Kuru Toz İnhaler Formülasyonları

AKDAĞ ÇAYLI Y., ŞAHİN S., ÖNER L.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 - 02 Haziran 2017

Development and Validation of an HPLC method for Simultaneous Determination of Ciprofloxacin Levofloxacin and N acetylcysteine

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Evaluation of Surfactant Effect on the Saturation Solubility and Permeability of Deferasirox

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Levofloxacin Dry Powder for Inhalation by Spray Drying Method

AKDAĞ ÇAYLI Y., ŞAHİN S., Buttini F., Balducci A. G., Montanari S., VURAL İ., et al.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Effect of Particle Size on Deferasirox Dissolution Time

GÜLSÜN İNAL T., AKDAĞ ÇAYLI Y., İZAT N., ÖNER L., ŞAHİN S.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Determination of Permeability of Ciprofloxacin Dry Powder Inhaler Formulations Across Calu 3 Cell Line

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Formulation and Characterization of Mometasone Furoate Monohydrate and Formoterol Fumarate Dihydrate Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L., ŞAHİN S.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Development and Evaluation of Terbutaline Sulfate Containing Orally Disintegrating Tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., KAYNAK M. S., ÖNER L., ŞAHİN S.
2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016

Determination and Evaluation of Aerodynamic Parameters of Ciprofloxacin and Mucolytic Containing Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., BUTTINI F., BALDUCCI A. G., MONTANARI S., VURAL İ., et al.
The Globalization of Pharmaceutics Education Network (GPEN) 2016, 9 - 12 Kasım 2016

Development and Validation of an HPLC Method for Determination of Rofecoxib

DEMİRTÜRK E., İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ŞAHİN S., ÖNER L.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016

Preparation and Evaluation of Lyophilized Orally Disintegrating Tablets Containing Terbutaline Sulphate

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., DEMİRTÜRK E., ÇETİN M., ÖNER L., et al.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016

EVALUATION OF PERMEABILITY OF LEVOFLOXACIN CONTAINING DRY POWDER INHALER ACROSS CALU 3 CELL LINE

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016

Development and In vitro Evaluation of Deferasirox Orally Disintegrating Tablets by Lyophilization Method

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., DEMİRTÜRK E., ÇETİN M., ÖNER L., et al.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016

Influence of Verapamil On Metformin Permeability Across Caco 2 Cells

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L., ŞAHİN S.
1st International Gazi Pharma Symposium Series, 12 - 15 Kasım 2015

Development of Metformin Hydrochloride and Glyburide Containing Orally Disintegrating Tablets

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., KAYNAK M. S., ÖNER L., ŞAHİN S.
2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015

Preparation and Evaluation of Deferasirox Containing Orally Disintegrating Tablets by Direct Compression Method

AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ŞAHİN S., ÖNER L.
2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015

Formulation and Characterization of Ciprofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015

Evaluation of Dissolution Results of Commercially Available Metformin Hydrochloride Tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ÖNER L., ŞAHİN S.
2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015

Formulation and Characterization of Levofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
3rd International TB-Meeting, 14 - 16 Ekim 2015

Investigation of permeabilities of metformin and glyburide from orally disintegrating tablets

ŞAHİN S., GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., ÖNER L.
6th BBBB Conference on Pharmaceutical Sciences, 10 - 12 Eylül 2015

Permeability studies of orally disintegrating tablets containing deferasirox

ŞAHİN S., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., İZAT N., ÖNER L.
6th BBBB Conference on Pharmaceutical Sciences, 10 - 12 Eylül 2015

Investigation of metformin permeability from commercially available metformin hydrochloride tablets

ŞAHİN S., İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., ÖNER L.
6th BBBB Conference on Pharmaceutical Sciences, 10 - 12 Eylül 2015

Formulation and Characterization of Antibiotic and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
1st European Conference on Pharmaceutics : Drug Delivery, 13 - 14 Nisan 2015

Formulation and Characterization of Ciprofloxacin Nanoparticles for Use in Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.
17th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014

Metrikler

Yayın

62

Atıf (WoS)

71

H-İndeks (WoS)

5

Atıf (Scopus)

136

H-İndeks (Scopus)

7

Proje

9

Açık Erişim

6
BM Sürdürülebilir Kalkınma Amaçları